NB-OLANZAPINE DIN 02570734
Health Canada record
| Active ingredient(s) | OLANZAPINE 15 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N05AH03 OLANZAPINE |
| Original market date | |
| Current status date | 07-Aug-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
NB Pharma Inc. — licence 3-002798, currently licensed, last inspection rating C (2025-12-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing OLANZAPINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02333015 | APO-OLANZAPINE | APOTEX INC | Tablet | OLANZAPINE 20 MG | Marketed |
| 02281848 | APO-OLANZAPINE | APOTEX INC | Tablet | OLANZAPINE 15 MG | Marketed |
| 02281821 | APO-OLANZAPINE | APOTEX INC | Tablet | OLANZAPINE 10 MG | Marketed |
| 02281791 | APO-OLANZAPINE | APOTEX INC | Tablet | OLANZAPINE 2.5 MG | Marketed |
| 02281805 | APO-OLANZAPINE | APOTEX INC | Tablet | OLANZAPINE 5 MG | Marketed |
| 02281813 | APO-OLANZAPINE | APOTEX INC | Tablet | OLANZAPINE 7.5 MG | Marketed |
| 02360624 | APO-OLANZAPINE ODT | APOTEX INC | Tablet (Orally-Disintegrating) | OLANZAPINE 10 MG | Marketed |
| 02360616 | APO-OLANZAPINE ODT | APOTEX INC | Tablet (Orally-Disintegrating) | OLANZAPINE 5 MG | Marketed |
| 02360640 | APO-OLANZAPINE ODT | APOTEX INC | Tablet (Orally-Disintegrating) | OLANZAPINE 20 MG | Marketed |
| 02360632 | APO-OLANZAPINE ODT | APOTEX INC | Tablet (Orally-Disintegrating) | OLANZAPINE 15 MG | Marketed |
| 02448726 | AURO-OLANZAPINE ODT | AURO PHARMA INC | Tablet (Orally-Disintegrating) | OLANZAPINE 5 MG | Marketed |
| 02417251 | JAMP OLANZAPINE FC | JAMP PHARMA CORPORATION | Tablet | OLANZAPINE 5 MG | Marketed |
| 02417308 | JAMP OLANZAPINE FC | JAMP PHARMA CORPORATION | Tablet | OLANZAPINE 20 MG | Marketed |
| 02417286 | JAMP OLANZAPINE FC | JAMP PHARMA CORPORATION | Tablet | OLANZAPINE 10 MG | Marketed |
| 02417243 | JAMP OLANZAPINE FC | JAMP PHARMA CORPORATION | Tablet | OLANZAPINE 2.5 MG | Marketed |
| 02417294 | JAMP OLANZAPINE FC | JAMP PHARMA CORPORATION | Tablet | OLANZAPINE 15 MG | Marketed |
| 02406624 | JAMP OLANZAPINE ODT | JAMP PHARMA CORPORATION | Tablet (Orally-Disintegrating) | OLANZAPINE 5 MG | Marketed |
| 02406632 | JAMP OLANZAPINE ODT | JAMP PHARMA CORPORATION | Tablet (Orally-Disintegrating) | OLANZAPINE 10 MG | Marketed |
| 02410176 | MINT-OLANZAPINE | MINT PHARMACEUTICALS INC | Tablet | OLANZAPINE 7.5 MG | Marketed |
| 02410184 | MINT-OLANZAPINE | MINT PHARMACEUTICALS INC | Tablet | OLANZAPINE 10 MG | Marketed |
| 02410141 | MINT-OLANZAPINE | MINT PHARMACEUTICALS INC | Tablet | OLANZAPINE 2.5 MG | Marketed |
| 02410192 | MINT-OLANZAPINE | MINT PHARMACEUTICALS INC | Tablet | OLANZAPINE 15 MG | Marketed |
| 02436981 | MINT-OLANZAPINE ODT | MINT PHARMACEUTICALS INC | Tablet (Orally-Disintegrating) | OLANZAPINE 15 MG | Marketed |
| 02436973 | MINT-OLANZAPINE ODT | MINT PHARMACEUTICALS INC | Tablet (Orally-Disintegrating) | OLANZAPINE 10 MG | Marketed |
| 02570718 | NB-OLANZAPINE | NB PHARMA INC. | Tablet | OLANZAPINE 7.5 MG | Approved |
| 02570688 | NB-OLANZAPINE | NB PHARMA INC. | Tablet | OLANZAPINE 2.5 MG | Approved |
| 02570696 | NB-OLANZAPINE | NB PHARMA INC. | Tablet | OLANZAPINE 5 MG | Approved |
| 02570726 | NB-OLANZAPINE | NB PHARMA INC. | Tablet | OLANZAPINE 10 MG | Approved |
| 02311984 | OLANZAPINE | PRO DOC LIMITEE | Tablet | OLANZAPINE 7.5 MG | Marketed |
| 02311992 | OLANZAPINE | PRO DOC LIMITEE | Tablet | OLANZAPINE 10 MG | Marketed |
| 02430444 | OLANZAPINE-ODT | JUBILANT GENERICS LIMITED | Tablet (Orally-Disintegrating) | OLANZAPINE 5 MG | Approved |
| 02303175 | PMS-OLANZAPINE | PHARMASCIENCE INC | Tablet | OLANZAPINE 10 MG | Marketed |
| 02303159 | PMS-OLANZAPINE | PHARMASCIENCE INC | Tablet | OLANZAPINE 5 MG | Marketed |
| 02303116 | PMS-OLANZAPINE | PHARMASCIENCE INC | Tablet | OLANZAPINE 2.5 MG | Marketed |
| 02303167 | PMS-OLANZAPINE | PHARMASCIENCE INC | Tablet | OLANZAPINE 7.5 MG | Marketed |
| 02303183 | PMS-OLANZAPINE | PHARMASCIENCE INC | Tablet | OLANZAPINE 15 MG | Marketed |
| 02303205 | PMS-OLANZAPINE ODT | PHARMASCIENCE INC | Tablet (Orally-Disintegrating) | OLANZAPINE 10 MG | Marketed |
| 02303191 | PMS-OLANZAPINE ODT | PHARMASCIENCE INC | Tablet (Orally-Disintegrating) | OLANZAPINE 5 MG | Marketed |
| 02303213 | PMS-OLANZAPINE ODT | PHARMASCIENCE INC | Tablet (Orally-Disintegrating) | OLANZAPINE 15 MG | Marketed |
| 02425114 | PRO-OLANZAPINE ODT | PRO DOC LIMITEE | Tablet (Orally-Disintegrating) | OLANZAPINE 20 MG | Marketed |
| 02310392 | SANDOZ OLANZAPINE | SANDOZ CANADA INCORPORATED | Tablet | OLANZAPINE 15.0 MG | Marketed |
| 02310341 | SANDOZ OLANZAPINE | SANDOZ CANADA INCORPORATED | Tablet | OLANZAPINE 2.5 MG | Marketed |
| 02310368 | SANDOZ OLANZAPINE | SANDOZ CANADA INCORPORATED | Tablet | OLANZAPINE 5.0 MG | Marketed |
| 02310384 | SANDOZ OLANZAPINE | SANDOZ CANADA INCORPORATED | Tablet | OLANZAPINE 10.0 MG | Marketed |
| 02327791 | SANDOZ OLANZAPINE ODT | SANDOZ CANADA INCORPORATED | Tablet (Orally-Disintegrating) | OLANZAPINE 15 MG | Marketed |
| 02327805 | SANDOZ OLANZAPINE ODT | SANDOZ CANADA INCORPORATED | Tablet (Orally-Disintegrating) | OLANZAPINE 20 MG | Marketed |
| 02327775 | SANDOZ OLANZAPINE ODT | SANDOZ CANADA INCORPORATED | Tablet (Orally-Disintegrating) | OLANZAPINE 5 MG | Marketed |
| 02327783 | SANDOZ OLANZAPINE ODT | SANDOZ CANADA INCORPORATED | Tablet (Orally-Disintegrating) | OLANZAPINE 10 MG | Marketed |
| 02359707 | TEVA-OLANZAPINE | TEVA CANADA LIMITED | Tablet | OLANZAPINE 20 MG | Marketed |
| 02276739 | TEVA-OLANZAPINE | TEVA CANADA LIMITED | Tablet | OLANZAPINE 7.5 MG | Marketed |
| 02276712 | TEVA-OLANZAPINE | TEVA CANADA LIMITED | Tablet | OLANZAPINE 2.5 MG | Marketed |
| 02276720 | TEVA-OLANZAPINE | TEVA CANADA LIMITED | Tablet | OLANZAPINE 5 MG | Marketed |
| 02276747 | TEVA-OLANZAPINE | TEVA CANADA LIMITED | Tablet | OLANZAPINE 10 MG | Marketed |
| 02276755 | TEVA-OLANZAPINE | TEVA CANADA LIMITED | Tablet | OLANZAPINE 15 MG | Marketed |
| 02327570 | ACT OLANZAPINE ODT | TEVA CANADA LIMITED | Tablet (Orally-Disintegrating) | OLANZAPINE 10 MG | Cancelled Post Market |
| 02348128 | OLANZAPINE | MELIAPHARM INC | Tablet | OLANZAPINE 5 MG | Cancelled Post Market |
| 02403072 | RAN-OLANZAPINE | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | OLANZAPINE 5.0 MG | Cancelled Post Market |
| 02403064 | RAN-OLANZAPINE | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | OLANZAPINE 2.5 MG | Cancelled Post Market |
| 02429632 | RAN-OLANZAPINE IR | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | OLANZAPINE 15 MG | Cancelled Pre Market |
| 02429616 | RAN-OLANZAPINE IR | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | OLANZAPINE 7.5 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 38072 | 2026-08-07 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing Agreement between two manufacturers |
International API supply for OLANZAPINE
14 valid EDQM Certificates of Suitability from 13 holders. 28 active FDA Drug Master Files.
Request a quote for NB-OLANZAPINE